Login

Switch On Your HIV Smarts.

Author Archives: Liz Highleyman

AIDS 2016: San Francisco and New York Lead in PrEP Use

AIDS 2016: San Francisco and New York Lead in PrEP Use

, by Liz Highleyman

The manufacturer of Truvada reported how many prescriptions have been filled for PrEP—with a steep rise among men in 2015. Read More

FDA Approves Epclusa Combo Pill for All Types of Hepatitis C

FDA Approves Epclusa Combo Pill for All Types of Hepatitis C

, by Liz Highleyman

Epclusa is a new combo pill of sofosbuvir/velpatasvir that can cure hepatitis C in 12 weeks. Read More

Generic hep C drugs as effective as high-cost brand names, plus other European Liver Conference highlights

Generic hep C drugs as effective as high-cost brand names, plus other European Liver Conference highlights

, by Liz Highleyman

Read more about the importance of early hepatitis C treatment, the best hep C drugs and expanding treatment access discussed at the European Liver Conference. Read More

FDA approves Descovy, an updated version of Truvada—but not for PrEP

FDA approves Descovy, an updated version of Truvada—but not for PrEP

, by Liz Highleyman

An updated tenofovir alafenamide combo pill is now available from Gilead Sciences, but it should not be substituted for Truvada as PrEP. Read More

Should there be more frequent STI screening for people on PrEP?

Should there be more frequent STI screening for people on PrEP?

, by Liz Highleyman

Current CDC guidelines recommend STI testing every 6 months, but this may not be frequent enough. Read More